International Aids Vaccine Initiative Inc
International Aids Vaccine Initiative Inc shows strong revenue growth and no reported officer compensation across recent filings.
EIN: 133870223 · New York, NY · NTEE: Q300 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $139.2M |
| Total Expenses | $132.9M |
| Program Spending | 85% |
| Net Assets | $63.9M |
| Transparency Score | 90/100 |
Is International Aids Vaccine Initiative Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
International Aids Vaccine Initiative Inc directs 85% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About International Aids Vaccine Initiative Inc
International Aids Vaccine Initiative Inc (EIN: 133870223) is a nonprofit organization based in New York, NY, classified under NTEE code Q300. The organization reported total revenue of $139.2M and total assets of $129.9M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of International Aids Vaccine Initiative Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
International Aids Vaccine Initiative Inc is a major nonprofit that has been operating for 30 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 6.5%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $129.7M |
| Total Expenses | $132.9M |
| Surplus / Deficit | $-3,217,837 |
| Total Assets | $124.2M |
| Total Liabilities | $60.3M |
| Net Assets | $63.9M |
| Operating Margin | -2.5% |
| Debt-to-Asset Ratio | 48.5% |
| Months of Reserves | 11.2 months |
Financial Health Grade: B
In 2023, International Aids Vaccine Initiative Inc reported a deficit of $3.2M with expenses exceeding revenue, holds 11.2 months of operating reserves (strong position), has a debt-to-asset ratio of 48.5% (moderate leverage).
Financial Trends
Over 13 years of filings (2011–2023), International Aids Vaccine Initiative Inc's revenue has grown at a compound annual growth rate (CAGR) of 6.5%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -11.7% | +1.3% | -3.7% |
| 2022 | +16.2% | +15.9% | +20.5% |
| 2021 | +30.1% | +17.8% | +31.0% |
| 2020 | +9.8% | +9.4% | +9.3% |
| 2019 | +14.6% | +5.3% | -10.3% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1996 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates International Aids Vaccine Initiative Inc with a Mission Score of 90 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 10%
- programs: 85%
- fundraising: 5%
According to IRS 990 filings, International Aids Vaccine Initiative Inc allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $3.2M, with expenses exceeding revenue.
- Debt-to-asset ratio: 48.5%.
Executive Compensation Analysis
The organization reports 0% officer compensation across all provided filing periods, indicating that no funds were allocated to executive salaries from the reported expenses, which is highly unusual and suggests either pro-bono leadership or compensation is categorized differently.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of International Aids Vaccine Initiative Inc's IRS 990 filings:
- Unclear executive compensation structure given 0% reported officer compensation, which may obscure how leadership is supported or compensated.
Strengths
The following positive indicators were identified for International Aids Vaccine Initiative Inc:
- Consistent and significant revenue growth from $52.4M in 2014 to $129.6M in 2023, demonstrating strong fundraising capabilities.
- Substantial asset base, with $124.2M in assets in 2023, indicating financial stability.
- No reported officer compensation across all provided periods, suggesting a high dedication of funds to mission-related activities.
- Regular and extensive IRS 990 filing history (13 filings), indicating a commitment to transparency.
- Strong program focus implied by the absence of reported officer compensation and the nature of its mission.
Frequently Asked Questions about International Aids Vaccine Initiative Inc
Is International Aids Vaccine Initiative Inc a legitimate charity?
International Aids Vaccine Initiative Inc (EIN: 133870223) is a registered tax-exempt nonprofit based in New York. Our AI analysis gives it a Mission Score of 90/100. It has 13 years of IRS 990 filings on record. Total revenue: $139.2M. 1 red flag identified. 5 strengths noted. Financial health grade: B.
How does International Aids Vaccine Initiative Inc spend its money?
International Aids Vaccine Initiative Inc directs 85% of its spending to programs and services. Fundraising costs 5%. This exceeds the 65% industry benchmark.
Are donations to International Aids Vaccine Initiative Inc tax-deductible?
International Aids Vaccine Initiative Inc is registered as a tax-exempt nonprofit (EIN: 133870223). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of International Aids Vaccine Initiative Inc's spending goes to programs?
International Aids Vaccine Initiative Inc directs 85% to programs, 5% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does International Aids Vaccine Initiative Inc compare to similar nonprofits?
With a transparency score of 90/100 (Excellent), International Aids Vaccine Initiative Inc is above average for NTEE category Q300 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is International Aids Vaccine Initiative Inc located?
International Aids Vaccine Initiative Inc is headquartered in New York, New York and files with the IRS under EIN 133870223. It is classified under NTEE code Q300.
How many years of IRS 990 filings does International Aids Vaccine Initiative Inc have?
International Aids Vaccine Initiative Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $139.2M in total revenue.
How does IAVI manage to report 0% officer compensation across all periods?
The provided data consistently shows 0% officer compensation. This could mean that executive leadership is entirely pro-bono, compensated through a related entity not reflected in this specific line item, or that compensation is categorized under other expense types not explicitly labeled as 'Officer Comp' in this summary.
What is the detailed breakdown of IAVI's program service expenses?
The provided summary data does not offer a detailed breakdown of program service expenses. A full IRS Form 990 would be required to understand the specific allocation of funds within its program activities, such as research, development, and advocacy.
Is IAVI's slight expense over revenue in 2023 a concern?
While expenses ($132,896,237) slightly exceeded revenue ($129,678,400) in 2023, this is a minor deficit relative to the organization's overall financial scale and substantial assets ($124,233,943). It does not appear to be a significant concern, especially given the organization's strong financial history and asset base.
Filing History
IRS 990 filing history for International Aids Vaccine Initiative Inc showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2011–2023), International Aids Vaccine Initiative Inc's revenue has grown by 114%, moving from $60.6M to $129.7M. Total assets increased by 25.5% over the same period, from $99.0M to $124.2M. Total functional expenses rose by 68.1%, from $79.1M to $132.9M. In its most recent filing year (2023), International Aids Vaccine Initiative Inc reported a deficit of $3.2M, with expenses exceeding revenue. The organization holds $60.3M in liabilities against $124.2M in assets (debt-to-asset ratio: 48.5%), resulting in net assets of $63.9M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $129.7M | $132.9M | $124.2M | $60.3M | — | — |
| 2022 | $146.8M | $131.2M | $128.9M | $62.7M | — | — |
| 2021 | $126.4M | $113.2M | $107.0M | $56.1M | — | View 990 |
| 2020 | $97.1M | $96.1M | $81.7M | $42.5M | — | — |
| 2019 | $88.5M | $87.8M | $74.8M | $37.1M | — | View 990 |
| 2018 | $77.2M | $83.4M | $83.4M | $46.2M | — | View 990 |
| 2017 | $80.5M | $85.4M | $82.0M | $38.0M | — | View 990 |
| 2016 | $65.0M | $73.9M | $89.2M | $42.1M | — | View 990 |
| 2015 | $72.4M | $67.7M | $85.1M | $28.2M | — | View 990 |
| 2014 | $52.5M | $60.0M | $92.7M | $40.0M | — | View 990 |
| 2013 | $66.4M | $58.7M | $105.1M | $29.3M | — | View 990 |
| 2012 | $61.5M | $69.1M | $90.2M | $21.7M | — | View 990 |
| 2011 | $60.6M | $79.1M | $99.0M | $22.7M | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $129.7M, expenses of $132.9M, and assets of $124.2M (revenue -11.7% year-over-year).
- 2022: Revenue of $146.8M, expenses of $131.2M, and assets of $128.9M (revenue +16.2% year-over-year).
- 2021: Revenue of $126.4M, expenses of $113.2M, and assets of $107.0M (revenue +30.1% year-over-year).
- 2020: Revenue of $97.1M, expenses of $96.1M, and assets of $81.7M (revenue +9.8% year-over-year).
- 2019: Revenue of $88.5M, expenses of $87.8M, and assets of $74.8M (revenue +14.6% year-over-year).
- 2018: Revenue of $77.2M, expenses of $83.4M, and assets of $83.4M (revenue -4.1% year-over-year).
- 2017: Revenue of $80.5M, expenses of $85.4M, and assets of $82.0M (revenue +23.8% year-over-year).
- 2016: Revenue of $65.0M, expenses of $73.9M, and assets of $89.2M (revenue -10.2% year-over-year).
- 2015: Revenue of $72.4M, expenses of $67.7M, and assets of $85.1M (revenue +38.0% year-over-year).
- 2014: Revenue of $52.5M, expenses of $60.0M, and assets of $92.7M (revenue -20.9% year-over-year).
- 2013: Revenue of $66.4M, expenses of $58.7M, and assets of $105.1M (revenue +8.0% year-over-year).
- 2012: Revenue of $61.5M, expenses of $69.1M, and assets of $90.2M (revenue +1.4% year-over-year).
- 2011: Revenue of $60.6M, expenses of $79.1M, and assets of $99.0M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for International Aids Vaccine Initiative Inc:
Data Sources and Methodology
This transparency report for International Aids Vaccine Initiative Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.